Correlation Between Rimon Consulting and Clal Biotechnology
Can any of the company-specific risk be diversified away by investing in both Rimon Consulting and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rimon Consulting and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rimon Consulting Management and Clal Biotechnology Industries, you can compare the effects of market volatilities on Rimon Consulting and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rimon Consulting with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rimon Consulting and Clal Biotechnology.
Diversification Opportunities for Rimon Consulting and Clal Biotechnology
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Rimon and Clal is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Rimon Consulting Management and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Rimon Consulting is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rimon Consulting Management are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Rimon Consulting i.e., Rimon Consulting and Clal Biotechnology go up and down completely randomly.
Pair Corralation between Rimon Consulting and Clal Biotechnology
Assuming the 90 days trading horizon Rimon Consulting Management is expected to generate 1.37 times more return on investment than Clal Biotechnology. However, Rimon Consulting is 1.37 times more volatile than Clal Biotechnology Industries. It trades about 0.43 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.05 per unit of risk. If you would invest 362,300 in Rimon Consulting Management on September 1, 2024 and sell it today you would earn a total of 79,400 from holding Rimon Consulting Management or generate 21.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rimon Consulting Management vs. Clal Biotechnology Industries
Performance |
| Timeline |
| Rimon Consulting Man |
| Clal Biotechnology |
Rimon Consulting and Clal Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rimon Consulting and Clal Biotechnology
The main advantage of trading using opposite Rimon Consulting and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rimon Consulting position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.| Rimon Consulting vs. Veridis Environment | Rimon Consulting vs. Homebiogas | Rimon Consulting vs. Electreon Wireless | Rimon Consulting vs. YH Dimri Construction |
| Clal Biotechnology vs. Bezeq Israeli Telecommunication | Clal Biotechnology vs. Brainsway | Clal Biotechnology vs. Mivne Real Estate | Clal Biotechnology vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |